Quantcast

Latest Stem cells Stories

2014-06-18 23:09:26

Cryo-Cell International is the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. Oldsmar, Fla (PRWEB) June 18, 2014 Cryo-Cell International, Inc., the world’s first cord blood bank, announced today that, after demonstrating compliance through an extensive inspection and auditing process with the NETCORD-FACT...

2014-06-18 12:18:46

Journal of Clinical Investigation Parkinson's disease, which affects millions worldwide, results from neuron loss. Transplantation of fetal tissue to restore this loss has shown promise, but ethical concerns over acquiring this tissue limit its use. In a June 17 study in the Journal of Clinical Investigation, Vania Broccoli and others at the San Raffaele Scientific Institute converted fibroblasts into neurons and engrafted them into the brains of rodents with parkinsonism. The cells...

Embryonic Stem Cells Offer Promising Treatment For Multiple Sclerosis
2014-06-17 03:34:58

University of Connecticut Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease. The researchers demonstrated that the embryonic stem cell therapy significantly reduced MS disease severity in animal models, and offered better treatment results than stem...

2014-06-17 12:25:17

Research demonstrates association between diversity of gut bacteria and survival WASHINGTON, June 17, 2014 /PRNewswire-USNewswire/ -- New research published online today in Blood, the Journal of the American Society of Hematology (ASH), suggests that the diversity of bacteria in the gastrointestinal tract of patients receiving stem cell transplants may be an important predictor of their post-transplant survival. A healthy gastrointestinal tract contains a balanced community of...

2014-06-17 10:29:40

Rice University Rice University scientists apply new theory to learn how and why cells differentiate How does a stem cell decide what path to take? In a way, it’s up to the wisdom of the crowd. The DNA in a pluripotent stem cell is bombarded with waves of proteins whose ebb and flow nudge the cell toward becoming blood, bone, skin or organs. A new theory by scientists at Rice University shows the cell’s journey is neither a simple step-by-step process nor all random....

2014-06-17 08:28:31

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited [ASX:NRT; NASDAQ:NVGN] and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the...

2014-06-17 08:28:27

Company to Present at BIO International Convention 2014 LOS ANGELES, June 17, 2014 /PRNewswire/ -- MAX BioPharma (www.maxbiopharma.com)announced today that it has successfully designed and synthesized proprietary small molecule oxysterols that are bone-targeted and possess potent osteogenic activity. The research was conducted as part of MAX BioPharma's first SBIR grant-supported activities in the area of osteoporosis. The company believes that these novel molecules are ideal...

2014-06-16 12:29:10

CAMBRIDGE, Mass., June 16, 2014 /PRNewswire/ -- Boston Biomedical, a company focused on the research and development of novel cancer therapeutics targeting cancer stem cells (CSC), today provided a summary of the clinical data presented at the 2014 American Society of Clinical Oncology (ASCO) 50(th) annual meeting, held from May 30 to June 3, 2014, in Chicago, IL. Clinical data were presented for BBI608 and BBI503, novel agents targeting cancer stem cells that have been developed by...

2014-06-16 08:27:24

BOTHELL, Wash., June 16, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues today announced that Nice, France-based TxCell (Euronext Paris: TXCL) a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T cells (Ag-Tregs)...

2014-06-13 23:04:15

Lab Testing Company Gives Back to Communities Across the Nation Alpharetta, GA (PRWEB) June 13, 2014 ANY LAB TEST NOW® is proud to announce that it is collecting donor specimens at selected locations across the U.S. on behalf of Delete Blood Cancer DKMS, an organization dedicated to helping people become bone marrow donors. The partnership which initially began in Indianapolis, Indiana; Greensboro, North Carolina; and Houston, Texas, is now officially offered at certain ANY LAB TEST...


Word of the Day
out-herod
  • In the phrase to out-herod Herod, to be more violent than Herod (as represented in the old mystery plays); hence, to exceed in any excess of evil.
Herod refers to 'Herod the Great,' a Roman client king and 'a madman who murdered his own family and a great many rabbis.' According to the OED, the term is 'chiefly with allusion to Shakespeare's use' in Hamlet.
Related